Abstract:Nanoparticles show great potential for drug delivery systems in cancer treatment and diagnosis, which mainly rely on the interaction between nanoparticles and living cells. However, there is still a lack of accurate and large field-of-view imaging techniques to reveal the aggregation and distribution behavior of nanoparticles in whole cancer cells without being destroyed. Here, we demonstrated quantitative imaging of unstained and intact mouse breast cancer cells (4T1) containing 50 nm gold nanoparticles ( NPs) using an X-ray scanning coherent diffraction imaging (ptychography) technique in a large field-of-view. A two-dimensional spatial resolution of 17 nm was achieved on the 4T1 cell. We combine X-ray ptychography and equally sloped tomography (EST) to perform three-dimensional structural mapping, distribution, and aggregation behavior of NPs in cancer cells. By taking full advantage of the large field-of-view, high-resolution, and quantitative imaging technique, the single intracellular NPs are observed and the amount of NPs in aggregations can be accurately quantified. In addition, the morphological changes of lysosomes containing NPs can be observed in the high-contrast mass density images. This study provides an approach for exploring quantitative analysis and physiological delivery of nanomaterials in intact cancer cells at nanoscale resolution, which may greatly benefit the interdisciplinary research of material science, nanomedicine, and nanotoxicology.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.0c05282?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.0c05282</a>.TEM images of the morphology of NPs before and after phagocytosis (Figure S1);STXM and ptychography images of 4T1 whole cells with NPs (Figure S2);thickness measurement of the 4T1 cell with an optical microscope (Figure S3);quantitative density analysis of NPs from the ptychography image (Figure S4);A set of projectional images reconstructed from diffraction patterns (Figure S5);A typical PSD curve and 2D projection of a part of the 4T1 cell used for 3D reconstruction (Figure S6);mass density distribution of a slice in the 3D reconstruction of the 4T1 cell with NPs (Figure S7);The amount of NPs contained in all aggregations and their phase shift values in <a class="internalNav" href="#fig4">Figure </a><a class="internalNav" href="#fig4">4</a> (Table S1);The calculation process of the mass density of NPs (Calculation S1); andradiation dose estimation for the 4T1 cell (Calculation S2). (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c05282/suppl_file/ac0c05282_si_001.pdf">PDF</a>)Dynamic display of 3D segmentation structures in the 4T1 cell reconstruction region (Movie S1) (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c05282/suppl_file/ac0c05282_si_002.avi">AVI</a>)This article has not yet been cited by other publications.

Testing a Nanoparticle Reagent for Imaging Mass Cytometry

Calibrating the Imaging and Therapy Performance of Magneto-Fluorescent Gold Nanoshells for Breast Cancer

Biomimetic Metallacage Nanoparticles with Aggregation-Induced Emission for NIR-II Fluorescence Imaging-Guided Synergistic Immuno-Phototherapy of Tumors

Lanthanide-Loaded Nanoparticles as Potential Fluorescent and Mass Probes for High-Content Protein Analysis

Metal-Labeled Aptamers As Novel Nanoprobes for Imaging Mass Cytometry Analysis

Zr-NMOF Tagged with Heterobifunctionalized Aptamers for Highly Sensitive, Multiplexed and Rapid Imaging Mass Cytometry

Aptamer Probes Labeled with Lanthanide-Doped Carbon Nanodots Permit Dual-Modal Fluorescence and Mass Cytometric Imaging

Complementary Nanoparticle Characterization by Resistive-Pulse Sensing, Electron Microscopy, and Charge Detection Mass Spectrometry

Immunolabeling lanthanide nanoparticles for alpha-fetoprotein measurement and cancer cells counting with detection of ICP-MS

Dextran-Encapsulated Nanoparticles and Super-Nanoparticle Assemblies: Preparation from Quantum Dots, Fluorescent Polymers, and Magnetic Nanoparticles for Application to Cellular Immunolabeling

Abstract 677: Increasing plexity of imaging mass cytometry for tumor tissue analysis

Revealing the In Situ Behavior of Aggregation-Induced Emission Nanoparticles and Their Biometabolic Effects via Mass Spectrometry Imaging

Optimizing the Structure of a Pt Metal-Chelating Polymer to Reduce Nonspecific Binding for Mass Cytometry

High-dimensional single-cell cartography tracking of immune cells subpopulation of mice peripheral blood treated with gold nanorods and black phosphorus nanosheets

Measuring Protein Biomarker Concentrations Using Antibody Tagged Magnetic Nanoparticles.

Nanoscale Detection of Subcellular Nanoparticles by X-Ray Diffraction Imaging for Precise Quantitative Analysis of Whole Cancer Cells

Dual-Color Fluorescence Imaging of Magnetic Nanoparticles in Live Cancer Cells Using Conjugated Polymer Probes

Cancer cell membrane-coated magnetic nanoparticles for MR/NIR fluorescence dual-modal imaging and photodynamic therapy.

Magnetic/Upconversion Fluorescent Nagdf4:Yb,Er Nanoparticle-Based Dual-Modal Molecular Probes for Imaging Tiny Tumors in Vivo

Long‐Term Intracellular Tracking of Label‐Free Nanoparticles in Live Cells and Tissues with Confocal Microscopy

Radiolabeled Human Protein-Functionalized Upconversion Nanoparticles for Multimodal Cancer Imaging